Muloc, Daelyn C.

HRN: 12-37-30  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
07/27/2022
08/03/2022
PO
3.5ml
BID
Multiple Soft Tissue Injuries
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: